The total number of COVID-19 deaths for Coles County was confirmed with IDPH to be 18 to date. To be sure, the uptick in cases hasn't approached the high marks in the spring, when the state regularly reported well over 1,000 new infections on a daily basis.
Of the 10-15 planned sites across the country, at least four in Pune are likely to be involved in human clinical trials of the Oxford University AstraZeneca Covid-19 vaccine . Around 1,600 people will participate in the clinical trial. It has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca.
Phase 2 and 3 clinical trials of the Oxford vaccine candidate is on in the United Kingdom, Phase 3 in Brazil and Phase 1 and 2 in South Africa. As large trials get underway to test the vaccines needed to stop the global coronavirus pandemic, one group has realized they are being left out and is not happy: People living with HIV.
Sanofi is leading the clinical development and registration of the COVID-19 vaccine and expects a Phase 1/ 2 study to start in September, followed by a Phase 3 study by the end of 2020. Other countries too, have been investing in a vaccine against the novel coronavirus, with Sanofi and GSK announcing a deal with Britain on Wednesday for 60 million doses.
Despite the positive numbers, he appealed for the wider public to "stay the course" and stick to the public health guidelines in place. Reuters reports that the average number of daily cases doubled from around 20 in recent weeks to over 40 over the past five days.
The drug is said to be an adenovirus-based vaccine which works by administering individuals with a gene from SARS SARS-CoV-2, the novel coronavirus that causes COVID-19, into the body. People with HIV are generally not part of the initial safety studies of vaccines, and they have often been excluded from late-stage clinical trials testing a vaccine's efficacy against a placebo, says AIDS researcher and physician David Hardy, a spokesperson for HIVMA.